Cell Source, INC

Cell Source, Inc. has appointed CBIZ CPAs P.C. as its new independent registered public accounting firm for the fiscal year ended December 31, 2024, following the resignation of Marcum LLP due to an acquisition, with previous audit reports from Marcum including an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.

Cell Source Inc. has successfully concluded a private offering of convertible notes, raising $4.76 million and issuing warrants for common stock.

Cell Source, Inc. reported a net loss of $1.48 million for Q1 2025, with significant increases in R&D expenses and interest costs, while actively pursuing capital raises to address going concern issues.

Cell Source Inc. reports a net loss of $4.18 million for the nine months ended September 30, 2024, alongside ongoing efforts to secure additional funding.

Cell Source Inc. reports a net loss of $2.76 million for the first six months of 2024 and expresses substantial doubt about its ability to continue as a going concern.

Cell Source Inc. reports a net loss for Q1 2024 and expresses concerns about its ability to continue as a going concern due to a working capital deficiency and past due notes.

Cell Source, Inc. has issued a $300,000 promissory note to Darlene Soave Revocable Trust, part of a series of similar notes, to secure funding.